Dialan, Ganiel A.

HRN: 19-58-87  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2022
OXACILLIN 500MG (VIAL)
04/08/2022
04/15/2022
IV
500mg
Q6h
T/C Acute Suppurative Appendicitis
Waiting Final Action 
04/08/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/08/2022
04/15/2022
IV
340mg
Q8h
T/C Acute Suppurative Appendicitis
Waiting Final Action 
04/08/2022
CEFTRIAXONE 1G (VIAL)
04/08/2022
04/15/2022
IV
2grams
OD
T/C Acute Suppurative Appendicitis
Waiting Final Action 
06/01/2023
CEFTRIAXONE 1G (VIAL)
06/01/2023
06/07/2023
IV
1g
OD
PCAP-C
Waiting Final Action 
06/01/2023
CEFTRIAXONE 1G (VIAL)
06/01/2023
06/07/2023
IV
1g
OD
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: